Synthekine
Initial Transaction Details
Transaction Date
June 2021
Purpose of Financing
Growth
Stage of Company
Early Stage
Structure of Financing
Equity
Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders. Using the principles of cytokine partial agonism and immunological specificity, Synthekine designs differentiated therapeutics to be both safe and efficacious.
Website